Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

about

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

Item

http://www.wikidata.org/entity/Q47645033

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@en

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@nl

type

Item

label

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@en

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@nl

altLabel

Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China

@en

prefLabel

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@en

Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.

@nl

P1476

Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China

@en

P2093

Chao Qiu

http://www.w3.org/2001/XMLSchema#string

Fujian Li

http://www.w3.org/2001/XMLSchema#string

Hairong Huang

http://www.w3.org/2001/XMLSchema#string

Hongyun Yin

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Min Zhu

http://www.w3.org/2001/XMLSchema#string

Na Wang

http://www.w3.org/2001/XMLSchema#string

Naihui Chu

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

P2860

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China

Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.

Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.

Clofazimine: current status and future prospects.

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

P31

scholarly article

P356

10.1128/AAC.02149-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yu Pang

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29378718

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

infectious disease

P932

5913945

http://www.w3.org/2001/XMLSchema#string